ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large Population of Chemotherapy Naive Patients With Advanced NSCLC By Ogkologos - April 16, 2015 610 0 Facebook Twitter Google+ Pinterest WhatsApp Final results from the IGNITE study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Consensus on Conceptual Framework for Precision Cancer Medicine in Germany July 20, 2020 How to Get Started With Exercising at Home During Cancer July 7, 2022 Cancer Screening Guidelines Often Lack Information on Potential Harms, Study Finds November 23, 2022 FDA Approves Niraparib and Abiraterone Acetate Plus Prednisone for BRCA2-mutated Metastatic Castration-Sensitive Prostate Cancer January 7, 2026 Load more HOT NEWS Physical Activity May Lessen the Effects of Chemobrain, Study Finds A celebration of peer review Teen Invents ‘Resilience Bra’ To Help Breast Cancer Patients With Post-Mastectomy... OncoNPC Classifier Identifies CUP Subgroups Sharing Characteristics with Predicted Primaries and...
